OsmoPrep® Lawyer & Lawsuit

A large number of colonoscopy patients have suffered from serious kidney damage (acute phosphate nephropathy) after using OsmoPrep bowel cleansing product. Given the serious nature of the injuries consumers were reporting, in 2008 the FDA required a black box warning be added to the labeling of this product. If you or a loved one…

Read More

Popular Birth Control Pills Given Revised Warning Labels

Birth control pills that contain drospirenone, otherwise known as fourth generation oral contraceptives, have recently become the subject of increasing distain within the healthcare community. Reports indicate that the use of such contraceptives may coincide with catastrophic complications. Of significant concern, however, is their recent association with the development of severe, life-threatening blood clots….

Read More

Victoza® Lawyer & Lawsuit

Victoza (generic: liraglutide) was approved by the U.S. Food and Drug Administration (FDA) to serve as a once-daily injection for the treatment of type 2 diabetes in some adults. Of significant concern, however, are the serious side effects that have recently been associated with clinically relevant Victoza exposure. Subsequently, Victoza treatment may place patients…

Read More

New Study: SSRIs May Be Responsible For a Twofold Increase In PPHN

Recent years have witnessed several antidepressant medications become the subject of increasingly critical skepticism. Compounding the criticism further are reports of new evidence that lends weight tot he long-suspected link between selective serotonin reuptake inhibitors (SSRIs) and congenital birth defects. According to a new study, the risk of a child developing persistent pulmonary hypertension…

Read More

Topamax® Side Effects

The U.S. Food & Drug Administration (FDA) has recently strengthened their initial warning on the drug Topamax (generic: topiramate). Previously, the Topamax medication was assigned to the Pregnancy Category C because of a lack of human data. However, they strengthened the warning to Category D as a direct result of new data that suggests…

Read More

Recent Dietary Supplement Lawsuit Holds Retailers, As Well As Manufacturers, Responsible for the Distribution of Tainted Products

Recent years have witnessed an influx of manufacturers incorporate active pharmaceutical ingredients into the development of dietary supplements. Accordingly, their actions suggest an attempt at increasing results without the hassles that accompany U.S. Food and Drug Administration (FDA) regulations. However, transgressions such as these are not only in violation of the Federal Food, Drug,…

Read More

Reumofan Plus Lawsuit

Reumofan Plus is touted as an all-natural dietary supplement that is administered in the treatment of arthritis, muscle pain, osteoporosis, bone cancer, and other conditions. However, a lab analysis conducted by the U.S. Food and Drug Administration (FDA) confirmed the presence of three undisclosed and potentially dangerous prescription drug ingredients in Reumofan Plus tablets….

Read More

Australia Becomes Latest Country to Warn Consumers of Dangerous DMAA Side Effects

In continuing with a recent global trend, several prominent healthcare regulatory agencies have begun to publicly express their concern regarding dietary supplements that contain DMAA. The most recent of which are Australian authorities who have warned consumers of the increased propensity for severe side effects that may coincide with the use of sports supplements…

Read More